Channels - Indole-3-Lactic Acid Attenuates IMQ-Induced Psoriasiform Dermatitis in Mice via AhR-Dependent Suppression of IL-17A :: FRELIP Discovery

Similar Items: Indole-3-Lactic Acid Attenuates IMQ-Induced Psoriasiform Dermatitis in Mice via AhR-Dependent Suppression of IL-17A

Quick Look
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
Quick Look
Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review
Quick Look
An 11‐Month‐Old Infant With Unusual Diaper Dermatitis
Quick Look
Corticosteroid Phobia in Patients with Atopic Dermatitis: A Narrative Review
Quick Look
Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region
Quick Look
Neurofunctional Reversibility in Psoriasis Vulgaris After IL-17A Inhibition: A Resting-State fMRI and Neurocognitive Analysis
Quick Look
Blistering Beetle Dermatitis Mimicking Herpes Zoster Ophthalmicus: a Case Report
Quick Look
The Importance of Achieving High Treatment Targets in Atopic Dermatitis: A Narrative Review
Quick Look
Do Medication Beliefs Influence Adherence to Topical Therapies in Patients With Atopic Dermatitis?
Quick Look
Topical Corticosteroid Phobia in Childhood Atopic Dermatitis: A Study Using the TOPICOP Score
Quick Look
Mental Health Among Caregivers of Children With Atopic Dermatitis: A Systematic Review With Meta‐Analysis
Quick Look
Dupilumab Can Be Effective for Immune-Related Adverse Event Dermatitis: A Case Report and Review of the Literature
Quick Look
Rapid Improvement of Acute Eczematous Facial Dermatitis During Pregnancy Following Stapokibart Therapy: A Case Report
Quick Look
Clinical Features and Risk Factors of Dermatitis Cruris Pustulosa et Atrophicans in Southwestern Uganda: A Cross-Sectional Study
Quick Look
Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
Quick Look
Successful Treatment of IL‐23 Inhibitor–Refractory Nail Psoriasis With Deucravacitinib: A Case Report
Quick Look
Incidence of Skin Infections in Patients with Atopic Dermatitis Treated with Topical Medications: A Cohort Study Using Japanese Claims Data
Quick Look
“Viral Suppression Among Rural and Urban People Living With HIV in Wyoming”
Quick Look
Corrigendum to “Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”
Quick Look
Biochemical Mechanisms Mediating the Immunomodulatory and Anti-Atopic Dermatitis Effects of GammaQ in a DNCB-Induced BALB/c Mouse Model
Quick Look
Prevalence and Burden of Somatic Symptom Disorder in Atopic Dermatitis and Chronic Pruritus—The Persistent Somatic Symptoms Across Diseases: Pruritus (SOMA.PRU) Study
Quick Look
REVEAL AD ‐ Prevalence of Moderate and Severe Atopic Dermatitis in Ireland: A Cross‐ Sectional, Real World Study of a Secondary Care Population
Quick Look
New Tuberculosis Infection and Reactivation of Tuberculosis in Patients with Psoriasis or Psoriatic Arthritis Receiving IL-23 Inhibitors: A Systematic Literature Review
Quick Look
Clinically Meaningful Improvements in Quality of Life, Including Sleep, With Two‐Week and Monthly Dosed Rademikibart: A Phase 2 Randomized Trial in Adults With Moderate‐to‐Severe Atopic Dermatitis